Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Goodwill & Intangibles: 2023-2024

Historic Goodwill & Intangibles for BioLineRx (BLRX) over the last 2 years, with Dec 2024 value amounting to $10.4 million.

  • BioLineRx's Goodwill & Intangibles was N/A to $10.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.4 million, marking a year-over-year change of. This contributed to the annual value of $10.4 million for FY2024, which is 29.66% down from last year.
  • According to the latest figures from FY2024, BioLineRx's Goodwill & Intangibles is $10.4 million, which was down 29.66% from $14.9 million recorded in FY2023.
  • In the past 5 years, BioLineRx's Goodwill & Intangibles registered a high of $14.9 million during FY2023, and its lowest value of $10.4 million during FY2024.
  • In the last 2 years, BioLineRx's Goodwill & Intangibles had a median value of $12.7 million in 2023 and averaged $12.7 million.
  • Data for BioLineRx's Goodwill & Intangibles shows a maximum YoY decreased of 29.66% (in 2024) over the last 5 years.
  • BioLineRx's Goodwill & Intangibles (Yearly) stood at $14.9 million in 2023, then fell by 29.66% to $10.4 million in 2024.